Looking At Merck & Co., Inc. (NYSE:MRK) From All Angles

Attractive stocks have exceptional fundamentals. In the case of Merck & Co., Inc. (NYSE:MRK), there's is a well-regarded dividend payer with a strong history of delivering benchmark-beating performance. In the following section, I expand a bit more on these key aspects. For those interested in digging a bit deeper into my commentary, take a look at the report on Merck here.

Solid track record established dividend payer

MRK delivered a triple-digit bottom-line expansion over the past couple of years, with its most recent earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 33%, which is an optimistic signal for the future.

For those seeking income streams from their portfolio, MRK is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 2.6%.

Next Steps:

For Merck, there are three essential factors you should further examine:

1. Future Outlook: What are well-informed industry analysts predicting for MRK’s future growth? Take a look at our free research report of analyst consensus for MRK’s outlook.
2. Financial Health: Are MRK’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of MRK? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.